Comparison of Robot-assisted Gait Training According to Gait Speed in Participants With Stroke

NCT ID: NCT03991364

Last Updated: 2019-06-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-01

Study Completion Date

2020-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of the experimental group that applied the speed of the robot-assisted gait training constantly and the control group that applied the gradual increase of the speed of the robot-assisted gait training.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Constant gait speed group

experimental group that applied the speed of the robot-assisted gait training constantly

Group Type EXPERIMENTAL

Constant gait speed group

Intervention Type OTHER

The speed of the robot-assisted gait treatment is constantly applied for 5 times a week for 2 weeks.

Increasing gait speed group

control group that applied the gradual increase of the speed of the robot-assisted gait training

Group Type OTHER

Increasing gait speed group

Intervention Type OTHER

The speed of the robot-assisted gait treatment is gradually increase for 5 times a week for 2 weeks.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Constant gait speed group

The speed of the robot-assisted gait treatment is constantly applied for 5 times a week for 2 weeks.

Intervention Type OTHER

Increasing gait speed group

The speed of the robot-assisted gait treatment is gradually increase for 5 times a week for 2 weeks.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Hemiplegic patients secondary to first cerebrovascular accidents
* Functional ambulation category score ≥ 3

Exclusion Criteria

* History of surgery of affected lower limb
* Fracture of affected lower limb
Minimum Eligible Age

19 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Rehabilitation Center, Seoul, Korea

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Joon-Ho Shin

Team manager

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Joon-Ho Shin, MS

Role: PRINCIPAL_INVESTIGATOR

National Rehabilitation Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

National Rehabilitation Center

Seoul, , South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Joon-Ho Shin, MS

Role: CONTACT

82-2-901-1884

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NRC-2019-01-002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.